These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21104404)

  • 1. Women's perspective of botulinum toxin treatment for overactive bladder symptoms.
    Digesu GA; Panayi D; Hendricken C; Camarata M; Fernando R; Khullar V
    Int Urogynecol J; 2011 Apr; 22(4):425-31. PubMed ID: 21104404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
    Rickey LM; Kenton K
    Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie JB; Vincent M; Herbison GP; Wilson DI; Wilson D
    Cochrane Database Syst Rev; 2011 Dec; (12):CD005493. PubMed ID: 22161392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of botulinum toxin in the treatment of refractory overactive bladder.
    Mucksavage P; Smith AL; Moy ML
    Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin in paediatric urology: a systematic literature review.
    DasGupta R; Murphy FL
    Pediatr Surg Int; 2009 Jan; 25(1):19-23. PubMed ID: 18953547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
    Sahai A; Khan M; Fowler CJ; Dasgupta P
    Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults.
    Tincello DG
    World J Urol; 2012 Aug; 30(4):451-6. PubMed ID: 22002834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin injections for adults with overactive bladder syndrome.
    Duthie J; Wilson DI; Herbison GP; Wilson D
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005493. PubMed ID: 17636801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
    Truzzi JC
    Rev Recent Clin Trials; 2015; 10(2):128-34. PubMed ID: 25880125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of botulinum toxin for genitourinary conditions: What is the evidence?
    da Silva CM; Chancellor MB; Smith CP; Cruz F
    Toxicon; 2015 Dec; 107(Pt A):141-7. PubMed ID: 26235907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin and refractory non-neurogenic overactive detrusor.
    Ksibi I; Godard AL; Azouvi P; Denys P; Dziri C
    Ann Phys Rehabil Med; 2009 Nov; 52(9):668-83. PubMed ID: 19729357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.
    Al Edwan GM; Mansi HH; Atta ONM; Shaath MM; Al Adwan R; Mahafza W; Afram KM; Ababneh O; Al Adwan D; Muheilan MM
    J Pediatr Surg; 2019 Mar; 54(3):595-599. PubMed ID: 29887168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.
    Cruz F; Silva C
    Curr Opin Urol; 2004 Nov; 14(6):329-34. PubMed ID: 15626874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Practical aspects of the use of botulinum toxin in the treatment of idiopathic overactive bladder].
    Szczypior M; Matuszewski M
    Wiad Lek; 2018; 71(4):888-892. PubMed ID: 30099430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes of overactive bladder with combined therapies of botulinum toxin injections and oral agents.
    Woll A; Edenfield A; Locke M; Swift S
    Int Urogynecol J; 2021 Oct; 32(10):2803-2806. PubMed ID: 33620537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of intravesical botulinum toxin-A injections in women with idiopathic overactive bladder symptoms.
    Marcelissen TA; Rahnama'i MS; Snijkers A; Schurch B; De Vries P
    World J Urol; 2017 Feb; 35(2):307-311. PubMed ID: 27272312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seniority of neurobladder and effectiveness of a first intradetrusor injection of botulinum toxin].
    Lacout M; Guinet-Lacoste A; Popoff M; Verollet D; Lebreton F; Amarenco G
    Prog Urol; 2015 Sep; 25(11):642-8. PubMed ID: 26094097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urologic applications of botulinum toxin.
    King A; Quirouet A; Moore CK
    Cleve Clin J Med; 2015 Jul; 82(7):456-64. PubMed ID: 26185945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
    Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
    J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.